FBL and acute lymphoblastic leukemia: Indeed, immunofluorescence analysis with an antibody against fibrillarin, a marker of nucleoli [25], revealed that 0.5 μmol/L MLN4924 treatment resulted in nucleolar disruption in all of the T-ALL cell lines examined (Figure 7B and Supplementary Figure 1).